Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisi...(on August 3 2007 was sufficient to appro...)

Date:8/19/2007

on August 3, 2007 was sufficient to approve the Merger. PharmAthene has consummated the Merger in accordance with the wishes of over 75% of Healthcare Acquisition Corp.'s stockholders who voted in favor of the Merger, but the board of directors of PharmAthene has made a determination to refrain from releasing the funds held in trust to PharmAthene absent a determination by the Delaware Court of Chancery that the Merger was validly approved and consummated. Accordingly, Plaintiff Matthew P. Kinley, a substantial stockholder of PharmAthene, commenced litigation in the Delaware Court of Chancery to determine the validity of the Merger.

During the hearing before the Delaware Court of Chancery at 2:00 p.m. on Monday, August 27, 2007, Plaintiff Matthew P. Kinley will ask the Court to issue a final order and judgment ruling that the Merger was validly approved and consummated in accordance with Delaware law. If granted, the final order and judgment would be binding on PharmAthene and all former, current and future stockholders of PharmAthene. Any stockholder who wishes to object to the Delaware Court of Chancery's confirmation of the validity of the Merger must either submit an objection in writing prior to the hearing or must appear in person or by counsel at the hearing. Failure to submit a timely objection or to appear at the hearing may preclude later challenge to the validity and consummation of the Merger. If you have any questions or concerns, you are urged to contact the PharmAthene representative listed below for more information.

The action filed by Plaintiff Matthew P. Kinley is captioned Matthew P. Kinley v. Healthcare Acquisition Corp., n/k/a PharmAthene, Inc., C.A. No. 3161-CC. A copy of the Complaint can be obtained from PharmAthene. The Answer to the Complaint that PharmAthene has filed admits the facts alleged therein and agrees that the request for judicial determination under 225(b) of the Delaware General Corporation Law is appropriate. The
'/>"/>

SOURCE PharmAthene, Inc. Copyright©2007 PR Newswire.

1 GOOD

Page: 1 2 3 4
Related biology technology :

1. Green County courts to hold hearings via video conferencing
2. Public Hearing Held for controversial anti-cloning bills
3. Delaware company will keep NameProtect here
4. Wisconsin Supreme Court to hear Menasha software case
5. Supreme Court limits foreign reach of U.S. patents
6. High court sends message on patent obviousness
7. Supreme Court ruling seen as blow to WARF stem cell patents
8. Software tax dispute could go the Supreme Court
9. Wisconsin court halts Abbotts sale of genotyping products
10. Wisconsin court affirms damages in Innogenetics, Abbott patent case
11. With patents, Wisconsin court gaining reputation as a "rocket docket"